ClinicalTrials.gg
CompletedNCT04529447Updated Jul 22, 2022

Response of Korean Medicine Hospital to COVID-19

An observational study in Covid19, sponsored by Jaseng Hospital of Korean Medicine. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2022-07-22.

Sponsored by Jaseng Hospital of Korean Medicine · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
485
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 90 studies in COVID-19 with a site in Korea, Republic of — 11 open to participants now, 19 under way, 6 of them phase 3. COVID-19 · Korea, Republic of.

Enrollment
11th of 18
485 · median 730
Started
2020
with 28 others
Observational
18 of 90
2 open now
Registered
17th of 90
by date

Among the 90 studies in COVID-19 with a site in Korea, Republic of, this one is the 11th largest by enrollment of the 18 observational ones that give a count, is one of 29 that started in 2020, is one of 18 observational ones, and was the 17th registered.

COVID-19

7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.

Browse COVID-19 studies →

Open to participants now

11 of the 90 studies in COVID-19 with a site in Korea, Republic of are open now. Recruiting first, the newest first:

6 more — sign in →

All 11 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 90 studies in COVID-19 with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures.

Read the detailed description

The objectives of this study are (1) to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital situated in Seoul, Korea, (2) to describe patient visit trends compared to the number of confirmed COVID-19 cases during the COVID-19 peak in February - April 2020, and (3) to provide results of a satisfaction survey regarding its preventive measures.

03

Conditions studied

  • Covid19

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Inpatients hospitalized and outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inpatients hospitalized at Jaseng Hospital of Korean medicine during March 23-25, 2020
  • Outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020

Exclusion criteria

Exclusion Criteria:

  • Visitors visiting Jaseng Hospital of Korean medicine during March 23-25, 2020 for purposes other than treatment
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
485 participants (actual)
Patient registry
No

Groups and cohorts

  • Patient satisfaction survey

    Jaseng Hospital of Korean medicine conducted a pen and paper survey on patient satisfaction with regard to its COVID-19 response in inpatients hospitalized and outpatients visiting during March 23-25, 2020.

    Other: Survey

Interventions

  • OtherSurvey

    The patient satisfaction survey consisted of 8 items, including 7 Likert scale questions and 1 multiple choice question.

06

What researchers measure

Primary outcomes

  1. Satisfactory service regarding hospital response to COVID-19

    Multiple choice question on satisfactory service regarding hospital response to COVID-19, if any

    Time frame: Baseline (time of current visit)

Secondary outcomes

  1. Feelings of apprehension regarding hospital visits

    Likert scale question on level of feelings of apprehension before hospital visits due to COVID-19

    Time frame: Baseline (time of current visit)

  2. Medical staff wearing of facial masks and hand hygiene

    Likert scale question on level of maintenance of wearing of facial masks and hand hygiene in medical staff

    Time frame: Baseline (time of current visit)

  3. Cleanliness and sterilization of hospital facilities

    Likert scale question on level of cleanliness and sterilization of hospital facilities with regard to COVID-19 spread prevention

    Time frame: Baseline (time of current visit)

  4. Convenience and accessibility of hand sanitizers

    Likert scale question on level of convenience and accessibility of hand sanitizers

    Time frame: Baseline (time of current visit)

  5. Helpfulness and readability of posters and stand-up banners

    Likert scale question on level of helpfulness and readability of posters and stand-up banners with COVID-19 information in the hospital

    Time frame: Baseline (time of current visit)

  6. Satisfaction with hospital safety measures for COVID-19

    Likert scale question on level of satisfaction with hospital safety measures for COVID-19

    Time frame: Baseline (time of current visit)

  7. Recommendation of hospital to friends and family

    Likert scale question on level of recommendation of this hospital to friends and family concerned with visiting hospitals due to COVID-19

    Time frame: Baseline (time of current visit)

07

Study locations

1 site
  • Jaseng Hospital of Korean Medicine
    Seoul, 06110, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2020 to primary completion in Aug 2020, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2020
First posted
Aug 27, 2020
StartActual
Jun 10, 2020
Primary completionActual
Aug 10, 2020
CompletionActual
Aug 10, 2020
Last update
Jul 22, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04529447
Lead sponsor
Jaseng Hospital of Korean Medicine
Responsible party
Sponsor
First posted
Aug 27, 2020
Start date
Jun 10, 2020
Primary completion
Aug 10, 2020
Completion
Aug 10, 2020
Last update
Jul 22, 2022

Study contacts

Jinho Lee, KMD, Ph.D.
study director · Jaseng Hospital of Korean Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion